Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection - PubMed (original) (raw)
Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection
M D Catalina et al. J Immunol. 2001.
Erratum in
- J Immunol 2001 Nov 15;167(10):6045
Abstract
Murine models of lymphocytic choriomeningitis virus infection suggest that the memory CD8(+) T cell repertoire is reflective of the CD8(+) T cell repertoire generated during acute infection. Less is known regarding the evolution of CD8(+) T cell repertoires during human viral infections. We therefore examined epitope-specific CD8(+) T cell responses in a large cohort of individuals with acute through latent Epstein-Barr virus infection. Using 16 of 20 published EBV epitopes restricted by HLA-A2, HLA-A3 or HLA-B7, we showed that lytic cycle-specific CD8(+) T cell responses predominated during acute EBV infection. However, whereas HLA-A2(+)-restricted BMLF-1-specific CD8(+) T cell responses were maintained through latency, HLA-A2(+)- and HLA-B7(+)-restricted BZLF-1, as well as HLA-A3(+)-restricted BRLF-1 CD8(+) T cell responses, were generated but not readily maintained. Analyses of CD8(+) T cell responses to EBV latent cycle Ags showed delayed detection and lower frequencies of latent epitope-specific CD8(+) T cell responses during acute EBV infection, with maintenance of these responses 1 yr post-EBV infection. Early BMLF-1 and EBNA-3A epitope-specific CD8(+) T cell frequencies did not correlate with their frequencies at 1 yr postinfection. Interestingly, populations of EBV-specific CD8(+) T cells were stable during 20 mo in our long term EBV-seropositive populations, suggesting homeostasis between virus and the host immune system. This study demonstrates that CD8(+) T cell repertoires generated during persistent viral infections are not simply reflective of the initial pool of CD8(+) T cells and provides evidence that the generation of CD8(+) T cell responses to a persistent infection is a dynamic process.
Similar articles
- Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF. Tan LC, et al. Arthritis Res. 2000;2(2):154-64. doi: 10.1186/ar80. Epub 2000 Feb 7. Arthritis Res. 2000. PMID: 11062606 Free PMC article. - Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
Catalina MD, Sullivan JL, Brody RM, Luzuriaga K. Catalina MD, et al. J Immunol. 2002 Apr 15;168(8):4184-91. doi: 10.4049/jimmunol.168.8.4184. J Immunol. 2002. PMID: 11937579 - Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.
Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Hislop AD, et al. J Exp Med. 2002 Apr 1;195(7):893-905. doi: 10.1084/jem.20011692. J Exp Med. 2002. PMID: 11927633 Free PMC article. - Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ. Ressing ME, et al. Semin Cancer Biol. 2008 Dec;18(6):397-408. doi: 10.1016/j.semcancer.2008.10.008. Epub 2008 Oct 25. Semin Cancer Biol. 2008. PMID: 18977445 Review. - Immunodominant CD8 T cell response to Epstein-Barr virus.
Houssaint E, Saulquin X, Scotet E, Bonneville M. Houssaint E, et al. Biomed Pharmacother. 2001 Sep;55(7):373-80. doi: 10.1016/s0753-3322(01)00082-8. Biomed Pharmacother. 2001. PMID: 11669500 Review.
Cited by
- Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.
Fang CH, Cheng YF, Lin SR, Lai WY, Liao LR, Chiu YL, Lee JM. Fang CH, et al. BMC Cancer. 2024 Aug 8;24(1):980. doi: 10.1186/s12885-024-12707-7. BMC Cancer. 2024. PMID: 39118069 Free PMC article. - Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M, Rufer N. Couturaud B, et al. Front Immunol. 2023 Nov 20;14:1293090. doi: 10.3389/fimmu.2023.1293090. eCollection 2023. Front Immunol. 2023. PMID: 38053994 Free PMC article. - Cross-reactivity influences changes in human influenza A virus and Epstein Barr virus specific CD8 memory T cell receptor alpha and beta repertoires between young and old.
Clark F, Gil A, Thapa I, Aslan N, Ghersi D, Selin LK. Clark F, et al. Front Immunol. 2023 Feb 24;13:1011935. doi: 10.3389/fimmu.2022.1011935. eCollection 2022. Front Immunol. 2023. PMID: 36923729 Free PMC article. - Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
Böni M, Rieble L, Münz C. Böni M, et al. Viruses. 2022 Dec 2;14(12):2709. doi: 10.3390/v14122709. Viruses. 2022. PMID: 36560713 Free PMC article. Review. - Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.
Reneau JC, Shindiapina P, Braunstein Z, Youssef Y, Ruiz M, Farid S, Hanel W, Brammer JE. Reneau JC, et al. J Clin Med. 2022 May 10;11(10):2699. doi: 10.3390/jcm11102699. J Clin Med. 2022. PMID: 35628826 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials